Group One Trading
NAGE

Group One Trading’s Niagen Bioscience NAGE Stock Holding History

Group One Trading’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.9K Sell
2,700
-50,700
-95% -$274K ﹤0.01% 6276
2025
Q4 		$340K Buy
53,400
+19,700
+58% +$137K ﹤0.01% 3893
2025
Q3 		$314K Sell
33,700
-51,400
-60% -$519K ﹤0.01% 4172
2025
Q2 		$1.23M Buy
85,100
+12,300
+17% +$121K ﹤0.01% 2582
2025
Q1 		$502K Buy
72,800
+14,800
+26% +$93K ﹤0.01% 3081
2024
Q4 		$308K Buy
58,000
+21,000
+57% +$115K ﹤0.01% 3567
2024
Q3 		$135K Buy
37,000
+16,200
+78% +$51K ﹤0.01% 3945
2024
Q2 		$56.8K Buy
20,800
+2,100
+11% +$7.03K ﹤0.01% 4430
2024
Q1 		$65.1K Sell
18,700
-39,200
-68% -$72.5K ﹤0.01% 4494
2023
Q4 		$82.8K Sell
57,900
-4,100
-7% -$5.71K ﹤0.01% 4618
2023
Q3 		$90.5K Buy
62,000
+27,800
+81% +$43.4K ﹤0.01% 4544
2023
Q2 		$53.7K Sell
34,200
-4,700
-12% -$7.01K ﹤0.01% 5216
2023
Q1 		$59.5K Sell
38,900
-2,500
-6% -$4.45K ﹤0.01% 4723
2022
Q4 		$69.6K Buy
+41,400
New +$65.6K ﹤0.01% 4754
2022
Q3 		– Sell
-23,700
Closed -$40K – 8391
2022
Q2 		$40K Sell
23,700
-18,500
-44% -$36.2K ﹤0.01% 5755
2022
Q1 		$104K Buy
42,200
+35,500
+530% +$97K ﹤0.01% 5458
2021
Q4 		$25K Sell
6,700
-109,700
-94% -$592K ﹤0.01% 6848
2021
Q3 		$730K Sell
116,400
-284,800
-71% -$2.35M ﹤0.01% 3769
2021
Q2 		$3.96M Buy
401,200
+5,600
+1% +$48.8K ﹤0.01% 1916
2021
Q1 		$3.69M Buy
+395,600
New +$3.14M 0.01% 1828
2020
Q1 		– Sell
-9,700
Closed -$42K – 5837
2019
Q4 		$42K Buy
+9,700
New +$34.5K ﹤0.01% 4087
2018
Q3 		– Sell
-18,800
Closed -$70K – 5681
2018
Q2 		$70K Hold
18,800
– – ﹤0.01% 3768
2018
Q1 		$79K Buy
18,800
+7,200
+62% +$37.7K ﹤0.01% 3396
2017
Q4 		$6.82M Buy
+11,600
New +$62.6K 0.05% 488

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's NAGE Position: Q1 2026 in Review

Group One Trading increased its Niagen Bioscience (NAGE) stake by 73% in Q1 2026, buying an estimated $40.3K and bringing the position to 17,755 shares worth $78.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4936.

Group One Trading first reported a position in NAGE in Q2 2016 and has held it in 21 quarters since. The position peaked at $5.78M in Q1 2021. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Group One Trading held 17,755 shares of Niagen Bioscience worth $78.3K as of Q1 2026.
  • Group One Trading bought 7,470 Niagen Bioscience shares in Q1 2026, an estimated $40.3K.
  • Niagen Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4936 holding.
  • Group One Trading first reported a position in Niagen Bioscience in Q2 2016 and has held it in 21 quarters since.
  • Group One Trading's Niagen Bioscience position peaked at $5.78M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.